CCC Intelligent Solutions Holdings Inc. Common Stock (NASDAQ:CCC) management said the company is entering its next phase with artificial intelligence moving from evaluation and testing into broader production use across its customer base.
Speaking at the JPMorgan Boston TMC Conference, CEO Githesh
Biosig Technologies (NASDAQ:STEX), operating as Streamex Corp, said its first quarter of 2026 marked a transition from product preparation to early commercialization, highlighted by the launch of its tokenized gold product, the payment of initial dividends to holders and the retirement of its conver
e.l.f. Beauty (NYSE:ELF) reported what executives described as a seventh consecutive year of “industry-leading” results, with fiscal 2026 net sales up 25% and adjusted EBITDA up 13%, while also signaling a more cautious near-term outlook for its core e.l.f. brand.
Chairman and Chief Executive Offic
Belite Bio (NASDAQ:BLTE) said it has begun a rolling New Drug Application submission to the U.S. Food and Drug Administration for Tinlarebant in Stargardt disease, while also accelerating preparations for a potential commercial launch.
On the company’s first-quarter 2026 earnings call, Chairman and
Intuit (NASDAQ:INTU) reported fiscal third-quarter revenue growth of 10% and raised its full-year outlook, while management outlined plans to reduce the company’s full-time workforce by 17% and adjust its approach to lower-income, price-sensitive tax filers.
Chairman and CEO Sasan Goodarzi said the
President Donald Trump wants a huge UFC fight in June at the White House to celebrate his birthday and the country. Netflix may have already overshadowed the big event.
